Trial
NCT00524134
P-glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy.
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
American Epilepsy Society; Milken Institute; GlaxoSmithKline
Condition
Epilepsy
Intervention
Carvedilol-CR
Why stopped
PI left the institution.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-05-23